Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis

Kidney International

Volumn 80, Issue 11, 2011, Pages 1170-1181

  Chen, Yi Ting ^a,b   Chang, Fan Chi ^a   Wu, Ching Fang ^a   Chou, Yu Hsiang ^a   Hsu, Huan Lun ^a   Chiang, Wen Chih ^a   Shen, Juqun ^c   Chen, Yung Ming ^a   Wu, Kwan Dun ^a   Tsai, Tun Jun ^a   Duffield, Jeremy S ^d   Lin, Shuei Liong ^a,e  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b E DA HOSPITAL   (Taiwan)

^c ELI LILLY AND COMPANY   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; GREEN FLUORESCENT PROTEIN; IMATINIB; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DAMAGE; CELL DIFFERENTIATION; CELL INFILTRATION; CELL PROLIFERATION; CELL PROTECTION; CELL TRANSFORMATION; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM INJURY; ENZYME ACTIVATION; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE DAMAGE; MACROPHAGE; MOUSE; MYOFIBROBLAST; NONHUMAN; PERICYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR BLOCKING; RENAL PROTECTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TARGET CELL; TRANSCRIPTION INITIATION; URETER OBSTRUCTION;

EID: 81155131228     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.208     Document Type: Article

References (59)

1. Lin SL, Kisseleva T, Brenner DA et al. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008; 173: 1617-1627.
2. Humphreys BD, Lin SL, Kobayashi A et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010; 176: 85-97.
3. Au P, Tam J, Duda DG et al. Paradoxical effects of PDGF-BB overexpression in endothelial cells on engineered blood vessels in vivo. Am J Pathol 2009; 175: 294-302.
4. Lindahl P, Johansson BR, Leveen P et al. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997; 277: 242-245. (Pubitemid 27446080)
5. Lindblom P, Gerhardt H, Liebner S et al. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev 2003; 17: 1835-1840. (Pubitemid 36944561)
6. Lin SL, Chang FC, Schrimpf C et al. Targeting endothelium-pericyte crosstalk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis. Am J Pathol 2011; 178: 911-923.
7. Rajkumar VS, Shiwen X, Bostrom M et al. Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing. Am J Pathol 2006; 169: 2254-2265. (Pubitemid 351181983)
8. Floege J, Eitner F, Alpers CE. A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 2008; 19: 12-23.
9. Cook HT. The origin of renal fibroblasts and progression of kidney disease. Am J Pathol 2010; 176: 22-24.
10. Klahr S, Harris K, Purkerson ML. Effects of obstruction on renal functions. Pediatr Nephrol 1988; 2: 34-42. (Pubitemid 18062344)
11. Heyman SN, Fuchs S, Jaffe R et al. Renal microcirculation and tissue damage during acute ureteral obstruction in the rat: effect of saline infusion, indomethacin and radiocontrast. Kidney Int 1997; 51: 653-663. (Pubitemid 27157948)
12. Rao S, Lobov IB, Vallance JE et al. Obligatory participation of macrophages in an angiopoietin 2-mediated cell death switch. Development 2007; 134: 4449-4458.
13. Darland DC, Massingham LJ, Smith SR et al. Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. Dev Biol 2003; 264: 275-288. (Pubitemid 37393463)
14. Visconti RP, Richardson CD, Sato TN. Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc Natl Acad Sci USA 2002; 99: 8219-8224. (Pubitemid 34651033)
15. Zhang J, Cao R, Zhang Y et al. Differential roles of PDGFR-alpha and PDGFR-beta in angiogenesis and vessel stability. FASEB J 2009; 23: 153-163.
16. Kuhnert F, Tam BY, Sennino B et al. Soluble receptor-mediated selective inhibition of VEGFR and PDGFRbeta signaling during physiologic and tumor angiogenesis. Proc Natl Acad Sci USA 2008; 105: 10185-10190.
17. Lin SL, Castano AP, Nowlin BT et al. Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J Immunol 2009; 183: 6733-6743.
18. Schmahl J, Raymond CS, Soriano P. PDGF signaling specificity is mediated through multiple immediate early genes. Nat Genet 2007; 39: 52-60. (Pubitemid 46026501)
19. Eng E, Holgren C, Hubchak S et al. Hypoxia regulates PDGF-B interactions between glomerular capillary endothelial and mesangial cells. Kidney Int 2005; 68: 695-703. (Pubitemid 43323125)
20. Floege J, Hudkins KL, Seifert RA et al. Localization of PDGF alpha-receptor in the developing and mature human kidney. Kidney Int 1997; 51: 1140-1150. (Pubitemid 27186540)
21. Seifert RA, Alpers CE, Bowen-Pope DF. Expression of platelet-derived growth factor and its receptors in the developing and adult mouse kidney. Kidney Int 1998; 54: 731-746. (Pubitemid 28397391)
22. Kliem V, Johnson RJ, Alpers CE et al. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 1996; 49: 666-678. (Pubitemid 26093075)
23. Tang WW, Ulich TR, Lacey DL et al. Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 1996; 148: 1169-1180. (Pubitemid 26108254)
24. Eitner F, Bucher E, van Roeyen C et al. PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis. J Am Soc Nephrol 2008; 19: 281-289. (Pubitemid 351240650)
25. Boor P, Konieczny A, Villa L et al. PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis. Nephrol Dial Transplant 2007; 22: 1323-1331. (Pubitemid 47072219)
26. Ostendorf T, van Roeyen CR, Peterson JD et al. A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis. J Am Soc Nephrol 2003; 14: 2237-2247. (Pubitemid 37052369)
27. Castano AP, Lin SL, Surowy T et al. Serum amyloid P inhibits fibrosis through FcgR-dependent monocyte-macrophage regulation in vivo. Sci Transl Med 2009; 1: 5ra13-15ra13.
28. Desmouliere A, Geinoz A, Gabbiani F et al. Transforming growth factorbeta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993; 122: 103-111. (Pubitemid 23188802)
29. Roy SG, Nozaki Y, Phan SH. Regulation of alpha-smooth muscle actin gene expression in myofibroblast differentiation from rat lung fibroblasts. Int J Biochem Cell Biol 2001; 33: 723-734. (Pubitemid 32520968)
30. Segerer S, Alpers CE. Chemokines and chemokine receptors in renal pathology. Curr Opin Nephrol Hypertens 2003; 12: 243-249. (Pubitemid 36578058)
31. Duffield JS, Tipping PG, Kipari T et al. Conditional ablation of macrophages halts progression of crescentic glomerulonephritis. Am J Pathol 2005; 167: 1207-1219. (Pubitemid 41541408)
32. Anders HJ, Vielhauer V, Frink M et al. A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J Clin Invest 2002; 109: 251-259. (Pubitemid 34083745)
33. Eis V, Luckow B, Vielhauer V et al. Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction. J Am Soc Nephrol 2004; 15: 337-347. (Pubitemid 38140774)
34. Freter RR, Alberta JA, Lam KK et al. A new platelet-derived growth factorregulated genomic element which binds a serine/threonine phosphoprotein mediates induction of the slow immediate-early gene MCP-1. Mol Cell Biol 1995; 15: 315-325.
35. Duffield JS, Forbes SJ, Constandinou CM et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005; 115: 56-65. (Pubitemid 40385505)
36. Buchdunger E, O'Reilly T, Wood J. Pharmacology of imatinib (STI571). Eur J Cancer 2002; 38(Suppl 5): S28-S36.
37. Wang S, Wilkes MC, Leof EB et al. Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo. FASEB J 2005; 19: 1-11. (Pubitemid 40069914)
38. Iyoda M, Hudkins KL, Becker-Herman S et al. Imatinib suppresses cryoglobulinemia and secondary membranoproliferative glomerulonephritis. J Am Soc Nephrol 2009; 20: 68-77.
39. Zoja C, Corna D, Rottoli D et al. Imatinib ameliorates renal disease and survival in murine lupus autoimmune disease. Kidney Int 2006; 70: 97-103. (Pubitemid 44000125)
40. Lassila M, Jandeleit-Dahm K, Seah KK et al. Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice. J Am Soc Nephrol 2005; 16: 363-373. (Pubitemid 41725131)
41. Bengatta S, Arnould C, Letavernier E et al. MMP9 and SCF protect from apoptosis in acute kidney injury. J Am Soc Nephrol 2009; 20: 787-797.
42. Iwano M, Plieth D, Danoff TM et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341-350. (Pubitemid 34847966)
43. Iwano M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens 2004; 13: 279-284. (Pubitemid 38582300)
44. Kriz W, Kaissling B, Le Hir M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest 2011; 121: 468-474.
45. Zeisberg M, Duffield JS. Resolved: EMT produces fibroblasts in the kidney/Pro/Con. J Am Soc Nephrol 2010; 21: 1247-1253.
46. Duffield JS, Humphreys BD. Origin of new cells in the adult kidney: results from genetic labeling techniques. Kidney Int 2011; 79: 494-501.
47. Bielesz B, Sirin Y, Si H et al. Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest 2010; 120: 4040-4054.
48. Koesters R, Kaissling B, Lehir M et al. Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol 2010; 177: 632-643.
49. Humphreys BD, Valerius MT, Kobayashi A et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2008; 2: 284-291. (Pubitemid 351298594)
50. Taura K, Miura K, Iwaisako K et al. Hepatocytes do not undergo epithelialmesenchymal transition in liver fibrosis in mice. Hepatology 2010; 51: 1027-1036.
51. Faulkner JL, Szcykalski LM, Springer F et al. Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis. Am J Pathol 2005; 167: 1193-1205. (Pubitemid 41541407)
52. Wiggins R, Goyal M, Merritt S et al. Vascular adventitial cell expression of collagen I messenger ribonucleic acid in anti-glomerular basement membrane antibody-induced crescentic nephritis in the rabbit. A cellular source for interstitial collagen synthesis in inflammatory renal disease. Lab Invest 1993; 68: 557-565.
53. Picard N, Baum O, Vogetseder A et al. Origin of renal myofibroblasts in the model of unilateral ureter obstruction in the rat. Histochem Cell Biol 2008; 130: 141-155.
54. Schrimpf C, Duffield JS. Mechanisms of fibrosis: the role of the pericyte. Curr Opin Nephrol Hypertens 2011; 20: 297-305.
55. Grgic I, Duffield JS, Humphreys BD. The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol; e-pub ahead of print 11 February 2011.
56. Endo T, Okuda T, Nakamura J et al. Exploring the origin of the cells responsible for regeneration and fibrosis in the kidneys. J Am Soc Nephrol 2010; 752 F-FC163 (Abstract).
57. Shen J, Vil MD, Jimenez X et al. Single variable domain-IgG fusion. A novel recombinant approach to Fc domain-containing bispecific antibodies. J Biol Chem 2006; 281: 10706-10714. (Pubitemid 43855492)
58. Shen J, Vil MD, Prewett M et al. Development of a fully human anti-PDGFRbeta antibody that suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody. Neoplasia 2009; 11: 594-604.
59. Lin SL, Chen RH, Chen YM et al. Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor. J Am Soc Nephrol 2005; 16: 2702-2713.